P41148 (ENPL_CANLF) Canis lupus familiaris (Dog) (Canis familiaris)
Endoplasmin UniProtKBInterProSTRINGInteractive Modelling
804 aa; Sequence (Fasta) ;
2 identical sequences: Vulpes vulpes: A0A3Q7TGF9; Nyctereutes procyonoides: A0A811YV33
It is possible new templates exist for this target since these models were created.
Available Structures
37 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of GRP94 in the active conformation | homo-2-mer | 2×ANP; | ||||
| Assess | ||||||
| Structure of full length GRP94 with AMP-PNP bound | homo-2-mer | 5×MG; 2×ANP; | ||||
| Assess | ||||||
| Structure of full length GRP94 with ADP bound | homo-2-mer | 4×MG; 2×ADP; | ||||
| Assess | ||||||
| Structure of Middle plus C-terminal domains (M+C) of GRP94 | homo-2-mer | |||||
| Assess | ||||||
| GRP94 in complex with the novel HSP90 Inhibitor Radester amine | homo-2-mer | 2×RDE; 8×PG4; 1×1PE; | ||||
| Assess | ||||||
| Structure of the N-domain of GRP94 bound to the HSP90 inhibitor PU-H54 | homo-2-mer | 2×P54; 4×IPA; 1×GOL; | ||||
| Assess | ||||||
| Structure of GRP94 with a resorcinylic inhibitor. | homo-2-mer | 6×SO4; 2×EQD; 9×EDO; | ||||
| Assess | ||||||
| GRP94 N-terminal Domain bound to geldanamycin | homo-2-mer | 2×GDM; 4×PG4; 1×1PE; | ||||
| Assess | ||||||
| GRP94 in complex with the novel HSP90 Inhibitor Radamide | homo-2-mer | 2×RDA; 4×PG4; 1×1PE; | ||||
| Assess | ||||||
| Ligand Induced Conformational Shift in the N-terminal Domain of GRP94, Open Conformation ADP-Complex | homo-2-mer | 2×MG; 2×ADP; 5×PG4; | ||||
| Assess | ||||||
| Ligand Induced Conformational Shift in the N-terminal Domain of GRP94, Open Conformation | homo-2-mer | 2×MG; 2×AMP; 5×PG4; | ||||
| Assess | ||||||
| Ligand Induced Conformational Shifts in the N-terminal Domain of GRP94, Open Conformation Complexed… | homo-2-mer | 2×MG; 2×ATP; 5×PG4; | ||||
| Assess | ||||||
| Structure of N-terminal plus middle domains (N+M) of GRP94 | monomer | |||||
| Assess | ||||||
| N-Domain Of Grp94 In Complex With the Novel Ligand N-Propyl Carboxyamido Adenosine | monomer | 1×MG; 1×PA7; 3×PG4; 1×1PE; | ||||
| Assess | ||||||
| Crystal Structure Of The N-Domain Of Grp94 Lacking The Charged Domain In Complex With Neca | monomer | 1×NEC; 2×PG4; | ||||
| Assess | ||||||
| Crystal Structure of the Unliganded Form of GRP94, the ER Hsp90: Basis for Nucleotide-Induced Confo… | monomer | 4×PG4; | ||||
| Assess | ||||||
| N-Domain Of Grp94 In Complex With the Novel Ligand N-(2-amino)ethyl Carboxyamido Adenosine | monomer | 1×N5A; 3×PG4; | ||||
| Assess | ||||||
| Crystal Structure of the N-domain of the ER Hsp90 chaperone GRP94 in complex with the specific liga… | monomer | 1×NEC; 1×M2M; | ||||
| Assess | ||||||
| Crystal Structure of the N-domain of the ER Hsp90 chaperone GRP94 in complex with Radicicol | monomer | 1×RDI; | ||||
| Assess | ||||||
| Crystal Structure of the N-domain of the ER Hsp90 chaperone GRP94 in complex with 2-chlorodideoxyad… | monomer | 1×CDY; 1×M2M; | ||||
| Assess | ||||||
| Grp94 N-domain bound to NEOCA | monomer | 2×PGE; 1×PG4; 1×N5O; | ||||
| Assess | ||||||
| N-Domain Of Grp94, with the Charged Domain, In Complex With the Novel Ligand N-Propyl Carboxyamido … | monomer | 1×PA7; 3×PG4; | ||||
| Assess | ||||||
| Crystal Structure of the Unliganded Form of GRP94, the ER Hsp90: Basis for Nucleotide-Induced Confo… | monomer | 4×PG4; | ||||
| Assess | ||||||
| N-Domain Of Grp94 In Complex With the 2-Iodo-NECA | monomer | 1×NEI; 5×PG4; | ||||
| Assess | ||||||
| GRP94 n-terminal domain bound to geldanamycin: effects of mutants 168-169 KS-AA | monomer | 1×GDM; 1×PG4; 2×PGE; | ||||
| Assess | ||||||
| N-Domain Of Grp94 Lacking The Charged Domain In Complex With Radicicol | monomer | 1×RDC; 4×PG4; 1×1PE; | ||||
| Assess | ||||||
| Structure of Grp94 bound to methyl 2-[2-(2-benzylpyridin-3-yl)ethyl]-3-chloro-4,6-dihydroxybenzoate… | monomer | 7×PE8; 2×PEG; 2×GOL; 1×VC4; | ||||
| Assess | ||||||
| Crystal Structure of the Unliganded Form of GRP94, the ER Hsp90: Basis for Nucleotide-Induced Confo… | monomer | 1×MG; 1×ADP; 6×PG4; | ||||
| Assess | ||||||
| Crystal Structure of the Unliganded Form of GRP94, the ER Hsp90: Basis for Nucleotide-Induced Confo… | monomer | 1×NEC; 3×PG4; | ||||
| Assess | ||||||
| Structure of Grp94 with methyl 3-chloro-2-(2-(1-(2-ethoxybenzyl)-1 H-imidazol-2-yl)ethyl)-4,6-dihyd… | monomer | 13×P33; 1×GOL; 1×V2C; | ||||
| Assess | ||||||
| Crystal structure of Grp94 bound to isoform-selective inhibitor methyl 2-(2-(1-(4-bromobenzyl)-1H-i… | monomer | 1×7KY; 1×PEG; | ||||
| Assess | ||||||
| Structure of GRP94 N-terminal Domain bound to resorcinylic inhibitor BnIm. | monomer | 4×EDO; 1×9QY; | ||||
| Assess | ||||||
| Structure of molecular chaperone Grp94 bound to selective inhibitor methyl 3-chloro-2-(2-{2-[(4-flu… | monomer | 1×VC1; 4×P33; | ||||
| Assess | ||||||
| Structure of molecular chaperone Grp94 bound to selective inhibitor methyl 2-[2-(2-benzylphenyl)eth… | monomer | 8×P33; 1×VC5; 1×GOL; | ||||
| Assess | ||||||
| Structure of GRP94 with a selective resorcinylic inhibitor. | monomer | 1×D57; 2×EDO; 2×PO4; | ||||
| Assess | ||||||
| N-Domain Of Grp94 In Complex With the Novel Ligand N-(2-hydroxyl)ethyl Carboxyamido Adenosine | monomer | 1×N5O; 4×PG4; | ||||
| Assess | ||||||
| Crystal structure of Grp94 bound to methyl 3-chloro-2-(2-(1-((5-chlorofuran-2-yl)methyl)-1H-imidazo… | monomer | 1×PGE; 8×GOL; 1×6C0; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2o1v.1.A | homo-2-mer | 0.74 | 2×ADP; | 98.91 | ||
| Assess | ||||||
| 5uls.1.A | homo-2-mer | 0.73 | 2×ANP; | 98.96 | ||
| Assess | ||||||
| 3bmy.1.A | monomer | 0.69 | 54.07 | |||
| Assess | ||||||